• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

SPDR Series Trust SPDR S&P Biotech ETF (NY:XBI)

85.93 +0.27 (+0.32%)
Official Closing Price Updated: 8:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,334,090
Open 84.83
Bid (Size) 85.77 (1)
Ask (Size) 86.07 (5)
Prev. Close 85.66
Today's Range 84.39 - 86.04
52wk Range 66.66 - 105.47
Shares Outstanding 541,500
Dividend Yield 0.03%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Donald Trump Is Finally Making Good On Pharma Tariffs Threats, But Stocks Yawn
July 16, 2025
President Donald Trump said late Tuesday his administration will begin implementing pharmaceutical tariffs next month. 
Via Investor's Business Daily
Topics ETFs Government World Trade
Trump Threatens To Slam Pharmaceuticals With Up To 200% Tariffs
July 08, 2025
President Donald Trump threatened Tuesday to levy up to 200% tariffs on drugs imported into the U.S. "very soon." 
Via Investor's Business Daily
Topics ETFs Economy Government

Performance

YTD
-6.1%
-6.1%
1 Month
+0.8%
+0.8%
3 Month
+4.0%
+4.0%
6 Month
-6.0%
-6.0%
1 Year
-10.9%
-10.9%

More News

Read More
Avadel Pharmaceuticals Under Fire? Investor Reportedly Demands Board Ouster, Sale Talks, $1B In Damages
June 29, 2025
Via Stocktwits
Topics ETFs Intellectual Property
Capricor Therapeutics Says FDA May Not Hold Advisory Committee Meeting For DMD Therapy Approval: Stock Soars But Analyst Issues Warning
June 24, 2025
Via Stocktwits
Capricor Stock Slumps 16% On Report Of Key FDA Executive’s Removal, But Retail’s Hopeful About New 4-Year Deramiocel Data
June 20, 2025
Via Stocktwits
FDA Completes Inspection of Capricor Therapeutics Manufacturing Facility For Deramiocel Approval: Retail Sees ‘Unimaginable Potential’
June 11, 2025
Via Stocktwits
Summit Therapeutics Stock Tumbles On Oncology Drug Trial Data, Retail Flags ‘Insane’ Valuation
May 30, 2025
Via Stocktwits
Topics Lawsuit Regulatory Compliance
Immunovant Stock Rises On Narrower-Than-Expected Q1 Loss: Retail’s Still On The Fence
May 29, 2025
Via Stocktwits
Hedge Funds Are Building A Towering Wall Of Bets Against Stocks
May 21, 2025
Via Benzinga
Here's How Trump Plans To Tackle Drug Prices, And Why It Might Not Work
May 20, 2025
Via Investor's Business Daily
Topics ETFs Government
Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment
May 19, 2025
Via Benzinga
Best Biotech Stocks to Buy in 2025
May 13, 2025
Via MarketBeat
Topics ETFs Economy Government
UniQure Narrows Q1 Loss But Revenue Plummets: Retail’s In Wait-And-Watch Mode
May 09, 2025
Via Stocktwits
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation
May 07, 2025
Via Benzinga
Capricor Therapeutics Stock Tumbles After FDA Confirms Intent To Hold Advisory Committee Meet For Deramiocel Approval: But Retail’s Optimistic
May 05, 2025
Via Stocktwits
Topics Economy Government
Large Cap Biopharmaceutical Update: Mixed Performance As Tariffs Loom
April 28, 2025
Via Talk Markets
Topics ETFs Stocks / Equities
Summit Therapeutics Stock Slumps After Partner Akeso Gets FDA Nod For Cancer Drug: Retail’s Optimistic
April 25, 2025
Via Stocktwits
Topics Artificial Intelligence
Immunovant Announces Roivant President Eric Venker As New CEO: Retail’s Elated
April 21, 2025
Via Stocktwits
Topics Government Retirement Stocks
uniQure Stock Jumps On FDA’s Breakthrough Therapy Designation For Investigational Gene Therapy: Retail’s Optimistic
April 17, 2025
Via Stocktwits
Topics Bankruptcy
Why Summit Therapeutics Rallied Double Digits Today on Another Down day for the Markets
April 10, 2025
Via The Motley Fool
Topics ETFs
Is It A Good Time To Trade Small Cap Biotech Stocks? - 3 Steps To Consider
April 07, 2025
Via Talk Markets
Topics ETFs Stocks / Equities
Biotech Weakness Ahead?
April 02, 2025
Via Talk Markets
Topics ETFs
Biotech Stocks Dive After Trump Tacks On 20% European Tariff. Why AbbVie, Merck Could Be Exposed.
April 02, 2025
Via Investor's Business Daily
Topics Economy Government World Trade
Retail Traders Mostly Bullish On Biotech Stocks Amid Blow From RFK Jr. Purge On Health Agencies
April 02, 2025
Via Stocktwits
Topics ETFs Government
Biotech Stocks Take Another Beating As 'Chaos' Reigns At FDA With Reports Of Mass Firings
April 01, 2025
Via Investor's Business Daily
Topics Workforce

Frequently Asked Questions

Is SPDR Series Trust SPDR S&P Biotech ETF publicly traded?
Yes, SPDR Series Trust SPDR S&P Biotech ETF is publicly traded.
What exchange does SPDR Series Trust SPDR S&P Biotech ETF trade on?
SPDR Series Trust SPDR S&P Biotech ETF trades on the New York Stock Exchange
What is the ticker symbol for SPDR Series Trust SPDR S&P Biotech ETF?
The ticker symbol for SPDR Series Trust SPDR S&P Biotech ETF is XBI on the New York Stock Exchange
What is the current price of SPDR Series Trust SPDR S&P Biotech ETF?
The current price of SPDR Series Trust SPDR S&P Biotech ETF is 85.93
When was SPDR Series Trust SPDR S&P Biotech ETF last traded?
The last trade of SPDR Series Trust SPDR S&P Biotech ETF was at 08/01/25 08:00 PM ET
What is the market capitalization of SPDR Series Trust SPDR S&P Biotech ETF?
The market capitalization of SPDR Series Trust SPDR S&P Biotech ETF is 46.53M
How many shares of SPDR Series Trust SPDR S&P Biotech ETF are outstanding?
SPDR Series Trust SPDR S&P Biotech ETF has 47M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap